RICHMOND, VA (WWBT) - Denny Hamlin's Short Track Showdown has reached new heights, and raised more money, since is moved from Southside Speedway to Richmond International Raceway. And the Action Track is not going to let it go.
For the third year in a row, the Denny Hamlin Short Track Showdown is set to open the Spring race weekend at RIR. The race, which typically features a dozen NASCAR drivers and celebrities battling on the ¾-mile track with some of the best local Late Model Stock Car drivers, will serve as a fundraiser for the Denny Hamlin Cystic Fibrosis Research Lab at the Children's Hospital of Richmond at VCU.
In 2012, the Denny Hamlin Foundation committed to a 3-year grant totaling $150,000 for the Children's Hospital of Richmond at VCU (CHoR). Funds from the grant, which are raised through events like this year's Denny Hamlin Short Track Showdown at Richmond International Raceway, will help accelerate the Denny Hamlin Cystic Fibrosis Research Lab's ability to bring new therapies to cystic fibrosis patients. In addition, the newly established Denny Hamlin Foundation Summer Scholars program will help train the next generation of CF research scientists.
The Denny Hamlin Short Track Showdown at Richmond International Raceway has brought some of the best late model racing action to Hamlin's hometown track for the past two years and is sure to provide another great show for fans who come out to support cystic fibrosis research.
"We are excited to once again host the Denny Hamlin Short Track Showdown at Richmond International Raceway," said RIR President Dennis Bickmeier in a release. "RIR is proud to partner with Denny to raise awareness and money that will assist one of the best research teams as they work to find a cure for cystic fibrosis."
The Denny Hamlin Short Track Showdown and BLUE OX 100 NASCAR K&N Pro Series East races will run on Thursday, April 25, as part of an action-packed opening day of the Spring NASCAR weekend at Richmond International Raceway.
Cystic Fibrosis is a fatal genetic disease that affects about 30,000 children and adults in the United States. CF causes chronic infections in the lungs and inadequate digestion of nutrients. There is no cure for CF, but medical advances have doubled the life expectancy of children in the last 30 years and increased the overall median age of survival to 38.
Children's Hospital of Richmond at VCU (CHoR) has a large research staff focused on finding a cure for CF. This research group has been critical in developing new therapies for CF. They recently discovered a promising CF lung disease treatment that is in development and undergoing pre-clinical testing at CHoR. As the only accredited CF center in the region, CF patients cared for at CHoR have access to the latest therapies and can participate in groundbreaking clinical studies.